Tvardi Therapeutics (TVRD) Total Liabilities: 2013-2017
Historic Total Liabilities for Tvardi Therapeutics (TVRD) over the last 5 years, with Sep 2017 value amounting to $9.0 million.
- Tvardi Therapeutics' Total Liabilities rose 7.46% to $9.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $9.0 million, marking a year-over-year increase of 7.46%. This contributed to the annual value of $13.1 million for FY2016, which is 123.87% up from last year.
- Per Tvardi Therapeutics' latest filing, its Total Liabilities stood at $9.0 million for Q3 2017, which was up 2.51% from $8.8 million recorded in Q2 2017.
- Tvardi Therapeutics' 5-year Total Liabilities high stood at $72.2 million for Q4 2013, and its period low was $4.0 million during Q2 2015.
- For the 3-year period, Tvardi Therapeutics' Total Liabilities averaged around $8.0 million, with its median value being $8.3 million (2016).
- As far as peak fluctuations go, Tvardi Therapeutics' Total Liabilities tumbled by 94.08% in 2014, and later surged by 138.15% in 2016.
- Quarterly analysis of 5 years shows Tvardi Therapeutics' Total Liabilities stood at $72.2 million in 2013, then slumped by 94.08% to $4.3 million in 2014, then soared by 37.01% to $5.9 million in 2015, then skyrocketed by 123.87% to $13.1 million in 2016, then climbed by 7.46% to $9.0 million in 2017.
- Its last three reported values are $9.0 million in Q3 2017, $8.8 million for Q2 2017, and $14.0 million during Q1 2017.